Jacobs Jeffrey W 4
4 · ARDELYX, INC. · Filed Nov 24, 2021
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Jacobs Jeffrey W
VP, Chemistry
Transactions
- Sale
Common Stock
2021-11-22$0.99/sh−754$748→ 119,483 total - Sale
Common Stock
2021-11-22$0.98/sh−5,000$4,882→ 120,237 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021.
- [F2]This transaction was executed in multiple trades in prices ranging from $0.96 to $0.992, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.